Clarivate PLC Highlights Global Research Impact with the 2026 Highly Cited Researchers List
Clarivate PLC (NYSE: CLVT), a global leader in scientific and academic information services, announced today the release of its 2026 Highly Cited Researchers list. The announcement, made in London, underscores the company’s commitment to fostering research integrity and providing a rigorous benchmark of scholarly influence amid heightened scrutiny of scientific credibility.
A Rigorous Evaluation Process
The list is derived from data within the Web of Science Core Collection, the flagship database managed by Clarivate. Analysts at the Institute for Scientific Information (ISI) apply stringent quantitative metrics alongside qualitative expert assessment to identify researchers whose work has exerted a broad, significant impact on their respective fields. This dual‑criteria approach ensures that the selected scholars truly shape the trajectory of global research.
Scale and Scope of Recognition
- 6,802 researchers were recognized in 2026, receiving a total of 7,090 awards across the globe.
- The honorees represent more than 1,200 institutions spanning 62 countries and regions.
- The United States remains the leading contributor, followed by Mainland China and the United Kingdom, illustrating the continued concentration of research excellence in these nations while highlighting a growing international diversity.
The 2026 list reflects trends in scientific collaboration, emerging disciplines, and the geographic redistribution of research talent. By publishing the data, Clarivate provides stakeholders—including funding bodies, universities, and policy makers—with a clear view of where influential research is concentrated and which institutions are fostering high‑impact scholars.
Implications for the Scientific Community
Clarivate’s release comes at a time when the integrity of research findings is under intense examination. By publicly acknowledging researchers who meet stringent influence criteria, Clarivate reinforces the standards of scientific excellence and helps maintain trust in the scholarly record. The list also serves as a strategic tool for institutions seeking to attract or retain top talent, and for funders aiming to allocate resources where they can generate the greatest intellectual return.
Clarivate’s Position in the Market
Operating from its London headquarters and listed on the New York Stock Exchange, Clarivate PLC commands a market capitalization of approximately $1.47 billion. The company’s diversified portfolio—including proprietary data products, analytics, and professional services—positions it at the nexus of scientific research, biopharma innovation, and intellectual property intelligence. Although its current price‑earnings ratio is –13.2, reflecting investment in growth and innovation, the firm’s share price has demonstrated resilience, trading at $2.19 on 2026‑11‑16, within a 52‑week range of $1.42 to $3.87.
Looking Ahead
As the scientific enterprise continues to evolve, Clarivate’s highly cited researcher initiative offers a transparent, data‑driven snapshot of where transformative research is happening. The company’s ongoing commitment to rigorous evaluation and global reach sets a standard for research benchmarking, reinforcing its role as a trusted partner for the academic and innovation communities worldwide.




